It is an important point but we cant at the moment say anything about that, he said. That rose to more than 85% after the second dose. The numbers were very small and there was uncertainty over their significance, said the researchers. The study was not set up to look at any differences between the two. He said the numbers were consistent with a relatively constant protection of about 70% at that stage.
the study to monitored the efficacy of the vaccine speak to one million people.
( z0 speak :ARG0 ( z1 study :ARG0-of ( z2 monitor :ARG1 ( z3 effective :ARG1 ( z4 vaccine ) ) ) ) :ARG2 ( z5 person :quant 1000000 ) )
(z0 / speak-01
    :ARG0 (z1 / study-01
              :ARG0-of (z2 / monitor-01
                           :ARG1 (z3 / effective-04
                                     :ARG1 (z4 / vaccine))))
    :ARG2 (z5 / person
              :quant 1000000))
the study to monitored the efficacy of the vaccine speak to one million people .
z1 :ARG0-of z2
z2 :ARG1 z3
z3 :ARG1 z4
z0 :ARG0 z1
z5 :quant 0
z0 :ARG2 z5